B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 6, Pages 860
Publisher
MDPI AG
Online
2017-05-30
DOI
10.3390/ijms18060860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells
- (2017) Ya Zhou et al. Oncotarget
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- VEGF-C and TGF-β reciprocally regulate mesenchymal stem cell commitment to differentiation into lymphatic endothelial or osteoblastic phenotypes
- (2016) YASUYUKI IGARASHI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance
- (2016) Lihua Shen et al. ONCOLOGY REPORTS
- Non-adherent culture induces paclitaxel resistance in H460 lung cancer cells via ERK-mediated up-regulation of βIVa-tubulin
- (2015) Korakot Atjanasuppat et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization
- (2015) Yi-Hui Wu et al. Oncotarget
- Addiction to B-MYB
- (2015) Oncotarget
- Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer
- (2015) Gab-Yong Bae et al. Oncotarget
- Cellular senescence and aging: the role of B-MYB
- (2014) Sophia N. Mowla et al. AGING CELL
- Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients
- (2013) Óscar Fuster et al. LEUKEMIA RESEARCH
- PRR11 is a novel gene implicated in cell cycle progression and lung cancer
- (2012) Ying Ji et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The ovarian cancer-derived secretory/releasing proteome: A repertoire of tumor markers
- (2012) Ying Zhang et al. PROTEOMICS
- B-Myb, Cancer, Senescence, and MicroRNAs
- (2011) I. Martinez et al. CANCER RESEARCH
- Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53
- (2011) Diego F. Calvisi et al. HEPATOLOGY
- Analysis of Transcriptome Differences between Resistant and Susceptible Strains of the Citrus Red Mite Panonychus citri (Acari: Tetranychidae)
- (2011) Bin Liu et al. PLoS One
- Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype
- (2010) Maddalena Frau et al. JOURNAL OF HEPATOLOGY
- Quantitative Secretome Analysis Reveals that COL6A1 is a Metastasis-Associated Protein Using Stacking Gel-Aided Purification Combined with iTRAQ Labeling
- (2010) Kuo-Hsun Chiu et al. JOURNAL OF PROTEOME RESEARCH
- SOAP2: an improved ultrafast tool for short read alignment
- (2009) R. Li et al. BIOINFORMATICS
- Activation of B-Myb by E2F1 in hepatocellular carcinoma
- (2008) Tomoaki Nakajima et al. HEPATOLOGY RESEARCH
- Mapping and quantifying mammalian transcriptomes by RNA-Seq
- (2008) Ali Mortazavi et al. NATURE METHODS
- In vitro and in vivo analysis of B-Myb in basal-like breast cancer
- (2008) A R Thorner et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now